Vascular smooth muscle contractile machinery and calcium handling pathways

The vascular smooth muscle contractile machinery and calcium handling pathways represent the integrated physiological system that regulates blood vessel diameter and peripheral resistance. This system relies on the precise control of intracellular calcium concentrations and the subsequent activation of the actin-myosin cross-bridge cycle. Contraction is typically initiated by calcium influx through L-type voltage-gated calcium channels or release from the sarcoplasmic reticulum, which activates myosin light chain kinase (MLCK) via a calmodulin-dependent mechanism [1][4]. This leads to the phosphorylation of the 20-kDa regulatory myosin light chain (MLC20) and force generation. Relaxation occurs when calcium levels drop and myosin light chain phosphatase (MLCP) dephosphorylates MLC20, a process often promoted by the nitric oxide-cGMP pathway [2][3]. Pathological alterations in these pathways, such as enhanced calcium sensitivity mediated by Rho-kinase (ROCK), contribute significantly to the development of hypertension and vasospastic disorders [3]. As such, components of this machinery are major therapeutic targets for antihypertensive and vasodilator medications, including calcium channel blockers and nitrates [3]. [1] StatPearls. Physiology, Smooth Muscle. https://www.ncbi.nlm.nih.gov/books/NBK526125/ [2] Webb, R. C. (2003). Smooth muscle contraction and relaxation. Advances in physiology education. https://doi.org/10.1152/advan.00025.2003 [3] Brozovich, F. V., et al. (2016). Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Hypertension. Pharmacological Reviews. https://doi.org/10.1124/pr.115.010652 [4] Kuo, I. Y., & Ehrlich, B. E. (2015). Signaling in muscle contraction. Cold Spring Harbor perspectives in biology. https://doi.org/10.1101/cshperspect.a006023

Other names

VSMC contraction-relaxation cycleVascular excitation-contraction couplingVascular tone regulation pathways

Inhibition of L-type voltage-gated calcium channels; Inhibition of Rho-associated protein kinase (ROCK); Activation of soluble guanylate cyclase (sGC); Inhibition of phosphodiesterase 5 (PDE5); Inhibition of myosin light chain kinase (MLCK).